Zomorodi K - Search Results

1

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

Yuen MF, Fung S, Ma X, Nguyen TT, Hassanein T, Hann HW, Elkhashab M, Nahass RG, Park JS, Jacobson IM, Ayoub WS, Han SH, Gane EJ, Zomorodi K, Yan R, Ma J, Knox SJ, Stamm LM, Bonacini M, Weilert F, Ramji A, Bennett M, Ravendhran N, Chan S, Dieterich DT, Kwo PY, Schiff ER, Bae HS, Lalezari J, Agarwal K, Sulkowski MS. Yuen MF, et al. Among authors: zomorodi k. JHEP Rep. 2024 Jan 18;6(4):100999. doi: 10.1016/j.jhepr.2023.100999. eCollection 2024 Apr. JHEP Rep. 2024. PMID: 38510983 Free PMC article.

2

Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study.

Agarwal K, Xu J, Gane EJ, Nguyen TT, Ding Y, Knox SJ, Alves K, Evanchik M, Zomorodi K, Ma J, Yan R, Huang Q, Colonno R, Stamm LM, Hassanein TI, Kim DJ, Lim YS, Yuen MF. Agarwal K, et al. Among authors: zomorodi k. J Viral Hepat. 2023 Mar;30(3):209-222. doi: 10.1111/jvh.13764. Epub 2023 Jan 12. J Viral Hepat. 2023. PMID: 36302125 Clinical Trial.

3

Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.

Junnarkar G, Allphin C, Profant J, Steininger TL, Chen C, Zomorodi K, Skowronski R, Black J. Junnarkar G, et al. Among authors: zomorodi k. Expert Opin Drug Discov. 2022 Feb;17(2):109-119. doi: 10.1080/17460441.2022.1999226. Epub 2021 Nov 24. Expert Opin Drug Discov. 2022. PMID: 34818123

4

Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP-458).

Lin T, Dumas T, Kaullen J, Berry NS, Choi MR, Zomorodi K, Silverman JA. Lin T, et al. Among authors: zomorodi k. Clin Pharmacol Drug Dev. 2021 Dec;10(12):1503-1513. doi: 10.1002/cpdd.1002. Epub 2021 Jul 26. Clin Pharmacol Drug Dev. 2021. PMID: 34310867 Free PMC article.

5

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.

Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA. Videnovic A, et al. Among authors: zomorodi k. Mov Disord. 2021 Oct;36(10):2408-2412. doi: 10.1002/mds.28702. Epub 2021 Jun 30. Mov Disord. 2021. PMID: 34191352 Free PMC article. Clinical Trial.

6

Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in two open-label, randomized, crossover studies.

Chen C, Jenkins J, Zomorodi K, Skowronski R. Chen C, et al. Among authors: zomorodi k. Clin Transl Sci. 2021 Nov;14(6):2278-2287. doi: 10.1111/cts.13087. Epub 2021 Jun 25. Clin Transl Sci. 2021. PMID: 34121333 Free PMC article. Clinical Trial.

7

A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants.

Zomorodi K, Chen D, Lee L, Swearingen D, Carter LP. Zomorodi K, et al. Clin Pharmacol Drug Dev. 2021 Apr;10(4):404-413. doi: 10.1002/cpdd.867. Epub 2020 Sep 15. Clin Pharmacol Drug Dev. 2021. PMID: 32935460 Free PMC article. Clinical Trial.

8

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight-Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy.

Chen C, Rosen CL, Ruoff C, Boyce LH, Parvataneni R, Zomorodi K, Brantley S, Sale M, Plazzi G. Chen C, et al. Among authors: zomorodi k. Clin Transl Sci. 2020 Sep;13(5):932-940. doi: 10.1111/cts.12780. Epub 2020 Apr 18. Clin Transl Sci. 2020. PMID: 32216084 Free PMC article. Clinical Trial.

9

Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.

Zomorodi K, Chen D, Lee L, Lasseter K, Marbury T. Zomorodi K, et al. J Clin Pharmacol. 2019 Aug;59(8):1120-1129. doi: 10.1002/jcph.1402. Epub 2019 Mar 13. J Clin Pharmacol. 2019. PMID: 30865315 Free PMC article. Clinical Trial.

10

A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.

Zomorodi K, Kankam M, Lu Y. Zomorodi K, et al. Clin Ther. 2019 Feb;41(2):196-204. doi: 10.1016/j.clinthera.2018.12.001. Epub 2018 Dec 28. Clin Ther. 2019. PMID: 30598342 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page